Search for: "Carr v. United States" Results 101 - 120 of 379
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2018, 9:01 pm
While these ordinances often contain a “criminal component”, municipalities rarely enforce the criminal penalties, but deem them necessary to cause compliance.Notwithstanding the laudable intentions behind this type of point of sale ordinance, and the usual reluctance of municipalities to enforce the criminal penalties associated therewith, the United States District Court for the Southern District of Ohio in Thompson V. [read post]
5 Mar 2018, 8:23 am by Julia Malleck
North Country (2005) North Country chronicles the story of the first class-action sexual harassment lawsuit in the United States, Jenson v. [read post]
23 Oct 2017, 3:00 am by Garrett Hinck
Deputy Assistant Secretaries of State Patrick Murphy and Marc Storella will testify alongside V. [read post]
12 Aug 2017, 2:44 am by Nicandro Iannacci
Carr (1962), recognizing judicial review of legislative apportionment; Engel v. [read post]
6 Aug 2017, 7:38 am by NCC Staff
Carr that the federal courts could intervene in state voter reapportionment cases. [read post]
5 May 2017, 11:37 am by Patricia Salkin
Carr (collectively, Wooster petitioners) and Buffalo Niagara Riverkeeper, Inc. commenced these CPLR article 78 proceedings seeking to annul the negative declaration issued by respondent City of Buffalo Planning Board under the State Environmental Quality Review Act (SEQRA) with respect to the proposed construction of Queen City Landing in Buffalo’s Outer Harbor area. [read post]
21 Apr 2017, 6:59 am by Brian Cordery
Penny sketched out the facts of the FKB v AbbVie litigation in the UK and the finding of Henry Carr J that it was appropriate to grant declarations that a dosage regime for a biosimilar product would have been anticipated or obvious at the priority date of a granted patent in the circumstances. [read post]
3 Mar 2017, 7:25 am
  Carr J , whilst noting that it was no reflection on the solicitor who had originally given the statement, stated that he did not believe AbbVie's explanation for its decision to abandon the '656 patent because it was not credible given the context. [read post]